Marjut Leidenius
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marjut Leidenius has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
K. von Smitten
Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, Finland
4 shared publications- Heikki Joensuu
Department of Oncology, Helsinki University Hospital and Helsinki University, Helsinki, Finland
3 shared publications - Jaana Vironen
Abdominal Centre, Helsinki University Hospital and University of Helsinki , Jorvi, Espoo
3 shared publications K.A.J. von Smitten
3 shared publicationsK. Salmenkivi
Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland
2 shared publicationsL.A. Krogerus
2 shared publications
Latest Publications
- Open Access
- 1 January 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (1) , 67-72
Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas
- 1 January 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (1) , 67-72
Open AccessComparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas
- 28 August 2021
- Published by Springer Nature
- p. 191-196
Decision-Making/Operative Planning
- Open Access
Human adipocyte differentiation and composition of disease-relevant lipids are regulated by miR-221-3p
MicroRNA-221-3p (miR-221-3p) is associated with both metabolic diseases and cancers. However, its role in terminal adipocyte differentiation, adipocyte lipid metabolism, and lipid signaling in human disease are uncharacterized. miR-221-3p or its inhibitor were transfected into differentiating or mature human adipocytes. Triglyceride (TG) content and adipogenic gene expression were monitored, global lipidome analysis was carried out, and mechanisms underlying the effects of miR-221-3p were investigated. Finally, cross-talk between miR-221-3p expressing adipocytes and MCF-7 breast carcinoma (BC) cells was studied, and miR-221-3p expression in tumor-proximal adipose biopsies from BC patients analyzed. miR-221-3p overexpression inhibited terminal differentiation of adipocytes, as judged from reduced TG storage and gene expression of the adipogenic markers SCD1, GLUT4, FAS, DGAT1/2, AP2, ATGL and AdipoQ . The signaling adaptor protein 14-3-3γ was identified as a potential mediator of the miR-221-3p effects. Importantly, miR-221-3p overexpression inhibited de novo lipogenesis but increased the concentrations of ceramides and sphingomyelins, while reducing diacylglycerols, concomitant with suppression of sphingomyelin phosphodiesterase, ATP citrate lyase, and acid ceramidase. miR-221-3p expression was elevated in tumor proximal adipose tissue from patients with invasive BC. Conditioned medium of miR-221-3p overexpressing adipocytes stimulated the invasion and proliferation of BC cells, while medium of the BC cells enhanced miR-221-3p expression in adipocytes. miR-221-3p plays a pivotal role in the terminal differentiation of white adipocytes and their lipid composition. Elevated miR-221-3p impairs adipocyte lipid storage and differentiation, and modifies their ceramide, sphingomyelin, and diacylglycerol content. These alterations are relevant for metabolic diseases but may also affect cancer progression.
Open AccessHuman adipocyte differentiation and composition of disease-relevant lipids are regulated by miR-221-3p
MicroRNA-221-3p (miR-221-3p) is associated with both metabolic diseases and cancers. However, its role in terminal adipocyte differentiation, adipocyte lipid metabolism, and lipid signaling in human disease are uncharacterized. miR-221-3p or its inhibitor were transfected into differentiating or mature human adipocytes. Triglyceride (TG) content and adipogenic gene expression were monitored, global lipidome analysis was carried out, and mechanisms underlying the effects of miR-221-3p were investigated. Finally, cross-talk between miR-221-3p expressing adipocytes and MCF-7 breast carcinoma (BC) cells was studied, and miR-221-3p expression in tumor-proximal adipose biopsies from BC patients analyzed. miR-221-3p overexpression inhibited terminal differentiation of adipocytes, as judged from reduced TG storage and gene expression of the adipogenic markers SCD1, GLUT4, FAS, DGAT1/2, AP2, ATGL and AdipoQ . The signaling adaptor protein 14-3-3γ was identified as a potential mediator of the miR-221-3p effects. Importantly, miR-221-3p overexpression inhibited de novo lipogenesis but increased the concentrations of ceramides and sphingomyelins, while reducing diacylglycerols, concomitant with suppression of sphingomyelin phosphodiesterase, ATP citrate lyase, and acid ceramidase. miR-221-3p expression was elevated in tumor proximal adipose tissue from patients with invasive BC. Conditioned medium of miR-221-3p overexpressing adipocytes stimulated the invasion and proliferation of BC cells, while medium of the BC cells enhanced miR-221-3p expression in adipocytes. miR-221-3p plays a pivotal role in the terminal differentiation of white adipocytes and their lipid composition. Elevated miR-221-3p impairs adipocyte lipid storage and differentiation, and modifies their ceramide, sphingomyelin, and diacylglycerol content. These alterations are relevant for metabolic diseases but may also affect cancer progression.
- 15 September 2017
- Published by Springer Nature
- p. 213-227
Surgery to the Breast: Breast Conservation Techniques
- 15 September 2017
- Published by Springer Nature
- p. 213-227
Surgery to the Breast: Breast Conservation Techniques
- 21 September 2015
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (1) , 64-70
Breast cancer prognosis and isolated tumor cell findings in axillary lymph nodes after core needle biopsy and fine needle aspiration cytology
- 21 September 2015
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (1) , 64-70
Breast cancer prognosis and isolated tumor cell findings in axillary lymph nodes after core needle biopsy and fine needle aspiration cytology
- 1 January 2015
- Published by Springer Nature
- p. 57-59
Inferior Rotation Flap: Caveat
- 1 January 2015
- Published by Springer Nature
- p. 53-55
Inferior Rotation Flap
- 9 October 2009
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (1) , 254-262
Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer
- 9 October 2009
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (1) , 254-262
Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer
- Open Access
- 15 July 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 231
Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer
There is evidence that the immune systems of patients with breast cancer are dysfunctional. Regulatory T cells (Tregs), and IDO, an immunosuppressive enzyme, are associated with more advanced disease in some cancers and may promote immunologic tolerance to tumors. Our aim was to assess whether expression of Foxp3, a marker of Tregs, and IDO were linked with nodal metastasis in breast cancer patients. Inhibitors of IDO are available and could potentially demonstrate utility in breast cancer if IDO drives progression of disease.
- 15 July 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 231
Open AccessSimultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer
There is evidence that the immune systems of patients with breast cancer are dysfunctional. Regulatory T cells (Tregs), and IDO, an immunosuppressive enzyme, are associated with more advanced disease in some cancers and may promote immunologic tolerance to tumors. Our aim was to assess whether expression of Foxp3, a marker of Tregs, and IDO were linked with nodal metastasis in breast cancer patients. Inhibitors of IDO are available and could potentially demonstrate utility in breast cancer if IDO drives progression of disease.
- 6 April 2009
- Published by Wiley in Journal of Surgical Oncology
- Vol. 99 (7) , 420-423
The outcome of sentinel node biopsy in breast cancer patients with preoperative surgical biopsy
Background: The aim of the study was to evaluate the outcome of sentinel node biopsy (SNB), especially the medium term axillary recurrence rate after negative SNB in patients with preoperative surgical biopsy (SB).Patients and Methods: The study included 1,641 patients with a histological stage T1 tumours and SNB. In 77 patients, the diagnosis was obtained with SB, while 1,564 patients had underwent needle biopsy (NB) only. Axillary clearance was omitted in 56 SB patients and 921 NB patients after negative SNB. The median duration of follow‐up in these patients was 54 months.Results: None of the SB patients had axillary recurrences during the follow‐up. Six NB patients had isolated axillary recurrences while three patients had concomitant local and axillary recurrences. There were no differences in local or distant recurrences or breast cancer deaths between the SB and the NB patients.Conclusions: SNB seems a feasible axillary staging method in patients with histological stage T1 tumour also after preoperative SB. The risk of axillary recurrence after negative SNB is negligible in these patients. J. Surg. Oncol. 2009;99:420–423.
- 6 April 2009
- Published by Wiley in Journal of Surgical Oncology
- Vol. 99 (7) , 420-423
The outcome of sentinel node biopsy in breast cancer patients with preoperative surgical biopsy
Background: The aim of the study was to evaluate the outcome of sentinel node biopsy (SNB), especially the medium term axillary recurrence rate after negative SNB in patients with preoperative surgical biopsy (SB).Patients and Methods: The study included 1,641 patients with a histological stage T1 tumours and SNB. In 77 patients, the diagnosis was obtained with SB, while 1,564 patients had underwent needle biopsy (NB) only. Axillary clearance was omitted in 56 SB patients and 921 NB patients after negative SNB. The median duration of follow‐up in these patients was 54 months.Results: None of the SB patients had axillary recurrences during the follow‐up. Six NB patients had isolated axillary recurrences while three patients had concomitant local and axillary recurrences. There were no differences in local or distant recurrences or breast cancer deaths between the SB and the NB patients.Conclusions: SNB seems a feasible axillary staging method in patients with histological stage T1 tumour also after preoperative SB. The risk of axillary recurrence after negative SNB is negligible in these patients. J. Surg. Oncol. 2009;99:420–423.